Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110.
Chae H, Augustin R, Gatineau E, Mayoux E, Bensellam M, Antoine N, Khattab F, Lai BK, Brusa D, Stierstorfer B, et al. (2020). SGLT2 is not expressed in pancreatic α- and β- cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans. Mol. Metab. 42, 101071.
Drose S. (2013). Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning. Biochim. Biophys. Acta 1827, 578-587.
Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. (2005). Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J. Clin. Endocrinol. Metab. 90, 493-500.
Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. (2014). Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953-966.
Ge T, Yang J, Zhou S, Wang Y, Li Y, Tong X. (2020). The Role of the Pentose Phosphate Pathway in Diabetes and Cancer. Front. Endocrinol. 11, 365.
Gheni G, Ogura M, Iwasaki M, Yokoi N, Minami K, Nakayama Y, Harada K, Hastoy B, Wu X, Takahashi H, et al. (2014). Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion. Cell Rep. 9, 661-673.
Giorgi C, Marchi S, Simoes ICM, Ren Z, Morciano G, Perrone M, Patalas-Krawczyk P, Borchard S, Jędrak P, Pierzynowska K, et al. (2018). Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases. Int. Rev. Cell Mol. Biol. 340, 209-344.
Guo S, Dai C, Guo M, Taylor B, Harmon JS, Sander M, Robertson RP, Powers AC, Stein R. (2013). Inactivation of specific beta cell transcription factors in type 2 diabetes. J. Clin. Invest. 123, 3305-3316.
Haythorne E, Rohm M, van de Bunt M, Brereton MF, Tarasov AI, Blacker TS, Sachse G, Silva Dos Santos M, Terron Exposito R, Davis S, et al. (2019). Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells. Nat Commun. 10, 2474.
Hallakou-Bozec S, Vial G, Kergoat M, Fouqueray P, Bolze S, Borel AL, Fontaine E, Moller DE. (2021). Mechanism of action of Imeglimin - A novel therapeutic agent for type 2 diabetes. Diabetes Obes. Metab. 23, 664-673.
Ivarsson R, Quintens R, Dejonghe S, Tsukamoto K, in ’t Veld P, Renström E, Schuit FC. (2005). Redox control of exocytosis. Regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54, 2132-2142.
Jitrapakdee S, Wutthisathapornchai A, Wallace JC, MacDonald MJ. (2010). Regulation of insulin secretion: role of mitochondrial signalling. Diabetologia 53, 1019-1032.
Kimura T, Obata A, Shimoda M, Okauchi S, Kanda-Kimura Y, Nogami Y, Moriuchi S, Hirukawa H, Kohara K, Nakanishi S, et al. (2018). Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β-cells in db/db mice: The earlier and longer, the better. Diabetes Obes. Metab. 20, 2442-2457.
Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. (2009). Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 47, 333-343.
Liu Y, Shi S, Gu Z, Du Y, Liu M, Yan S, Gao J, Li J, Shao Y, Zhong W, et al. (2013). Impaired autophagic function in rat islets with aging. Age 35, 1531-1544.
Liu YQ, Han J, Epstein PN, Long YS. (2005). Enhanced rat beta-cell proliferation in 60% pancreatectomized islets by increased glucose metabolic flux through pyruvate carboxylase pathway. Am. J. Physiol. Endocrinol. Metab. 288, E471-478.
MacDonald PE, Joseph JW, Rorsman P. (2005). Glucose-sensing mechanisms in pancreatic beta-cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360, 2211-2225.
Maechler P, Wollheim C. (1999). Mitochondrial glutamate acts as a messenger in glucose- induced insulin exocytosis. Nature 402, 685-689.
Mishra P, Chan DC. (2014). Mitochondrial dynamics and inheritance during cell division, development and disease. Nat. Rev. Mol. Cell Biol. 15, 634-646.
Molina AJ, Wikstrom JD, Stiles L, Las G, Mohamed H, Elorza A, Walzer G, Twig G, Katz S, Corkey BE, et al. (2009). Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 58, 2303-2315.
Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi R, Hatanaka KC, et al. (2019). Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. Metabolism 98, 27-36.
Owen MR, Doran E, Halestrap AP. (2000). Evidence that metformin exerts its anti- diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614.
Poitout V, Robertson RP. (2008). Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr. Rev. 29, 351-366.
Prentki M, Peyot ML, Masiello P, Madiraju SRM. (2020). Nutrient-induced metabolic stress, adaptation, detoxification, and toxicity in the pancreatic beta-cell. Diabetes 69, 279-290.
Quinlan CL, Orr AL, Perevoshchikova IV, Treberg JR, Ackrell BA, Brand MD. (2012). Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J. Biol. Chem. 287, 27255-27264.
Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, et al. (2003). Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun. 300, 216-222.
Takahashi K, Nakamura A, Miyoshi H, Nomoto H, Kitao N, Omori K, Yamamoto K, Cho K, Terauchi Y, Atsumi T. (2018). Effect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages. Sci. Rep. 8, 6864.
Taylor BL, Liu FF, Sander M. (2013). Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Rep. 4, 1262-1275
Tiedge M, Lortz S, Drinkgern J, Lenzen S. (1997). Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46, 1733-1742.
U.K. Prospective Diabetes Study Group. (1995). U.K. prospective diabetes study 16. Overview of 6 year’s therapy of type II diabetes: a progressive disease. Diabetes 44, 1249- 1258.
Vial G, Chauvin MA, Bendridi N, Durand A, Meugnier E, Madec AM, Bernoud-Hubac N, Pais de Barros JP, Fontaine É, Acquaviva C, et al. (2015). Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model. Diabetes 64, 2254-2264.
Xu J, Han J, Long YS, Epstein PN, Liu YQ. (2008). The role of pyruvate carboxylase in insulin secretion and proliferation in rat pancreatic beta cells. Diabetologia 51, 2022-2030.